A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor

NCT06239298 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: ZG005 Powder for Injection
DRUG: Donafenib Tosilate Tablets

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd